Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer.

Weijia WangXiuyun TianLiang YanXiaoya GuanBin DongMin ZhaoDaoning LiuJianhui WuChun-Yi Hao

Published in: Annals of medicine (2023)

The γ-glutamyl cycle and 5-oxoproline might be potential biomarkers and therapeutic targets to improve the diagnosis, therapy, and prognosis of PDAC.

Keyphrases